Investors are anticipating further rate hikes from the central banks in the UK, Norway and Switzerland later in the day. Among single stocks, Sanofi rose 3.9% after the French drugmaker said its asthma and eczema drug Dupixent, jointly developed with Regeneron , met all targets in a trial to treat "smoker's lung". (Reporting by Sruthi Shankar in Bengaluru; Editing by Subhranshu Sahu)
8780; outside U.S. +91 80 6182 2787;)) (For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
March 23 (Reuters) - European stocks opened lower on
Thursday, following a weak session on Wall Street a day earlier,
when the Federal Reserve delivered a widely expected 25
basis-point rate hike and signalled that a pause in policy
tightening could be near.
The continent-wide STOXX 600 index slipped 0.4% by
0808 GMT, after closing at its highest level in more than a week
on Wednesday.
U.S. stock futures , however, stabilised following a
turbulent session on Wall Street after the Fed lifted interest
rate to the 4.75%-5.00% range despite the recent banking
turmoil, but dropped language about "ongoing increases".
Meanwhile, U.S. Treasury Secretary Janet Yellen told
lawmakers that she had not considered or discussed "blanket
insurance" to banking deposits after the failure of two U.S.
mid-sized lenders earlier this month.
European banks fell 1% to lead sectoral losses.
Citigroup downgraded the sector, warning the rapid pace of
interest rate hikes would further weigh on economic activity and
lenders' profits.
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.